tiprankstipranks
Processa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
PremiumThe FlyProcessa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
4M ago
Processa Pharmaceuticals announces preclinical data for NGC-Iri
Premium
The Fly
Processa Pharmaceuticals announces preclinical data for NGC-Iri
4M ago
Processa Pharmaceuticals price target lowered to $6 from $8 at H.C. Wainwright
Premium
The Fly
Processa Pharmaceuticals price target lowered to $6 from $8 at H.C. Wainwright
4M ago
Processa announces results from preliminary eval of Phase 1b trial with NGC-Cap
PremiumThe FlyProcessa announces results from preliminary eval of Phase 1b trial with NGC-Cap
6M ago
Processa Pharmaceuticals files $50M  mixed securities shelf
Premium
The Fly
Processa Pharmaceuticals files $50M mixed securities shelf
7M ago
Processa Pharmaceuticals appoints Steven Cha as SVP, clinical research
Premium
The Fly
Processa Pharmaceuticals appoints Steven Cha as SVP, clinical research
8M ago
PCSA Earnings this Week: How Will it Perform?
PremiumPre-EarningsPCSA Earnings this Week: How Will it Perform?
9M ago
Processa Pharmaceuticals Secures NASDAQ Listing Compliance
Premium
Company Announcements
Processa Pharmaceuticals Secures NASDAQ Listing Compliance
11M ago
Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
Premium
The Fly
Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100